Annals of Internal Medicine

Bacterial overgrowth is a real problem, and it was recently described in a review paper published in the Journal of the American Medical Association, and it can be treated.

In fact, just recently, a major paper was published in the Annals of Internal Medicine that showed that using a non-absorbed antibiotic called rifamixin for 10 days resulted in dramatic improvement in bloating and overall symptoms of irritable bowel by clearing out the small bowel bacterial overgrowth.

That's very good news for irritable bowel patients.

But unfortunately, not all patients with the same diagnosis are created equal.

You know, I speak about this.

I wrote an article in the Annals of Internal Medicine this January on this, about the diagnosis of Alzheimer's and the treatment, et cetera, that there may be people that, based on biological plausibility, that perhaps we could alter trajectory of their course and possibly even prevent or delay significantly any cognitive impairment.

So that's my position.

And it's not the official position.

We're wasting 30 cents of every healthcare dollar on profit and administration and all this garbage.

A 2020 study published in the Annals of Internal Medicine found that administrative costs, including billing, insurance paperwork, and staffing, accounted for about one-third of U.S. healthcare spending in the areas studied, compared with just 17% in Canada.

If we just took all our healthcare dollars in our system and put them into healthcare, we could cover everybody.

We could give everybody vision.

which sharply increased the number of chronic infections and put more than half of Americans at risk of disease by age 20, according to a new study published.

And so here's the study in Annals of Internal Medicine.

We have the article, Projected Effect of 2026 Federal Changes to the Childhood Immunization Schedule on Chronic Hepatitis B Virus Infections in United States.

So here we have analysis where they... determined that compared with the universal birth dose strategy, 255 childhood infections, the deferred and shared decision-making strategies would increase chronic HPV infections in the 2026 birth cohort by 19% from that 255 to 303, and by 83% to 467, if you kind of follow that so these strategies would also increase the number of h hepatitis b virus susceptible people at age 20 and this is actually um 400 474 000 and 1 806 compared with this universal birth strategy where you'd only have 232 so pretty dramatic increases if we go down this road

So Vincent, are you ready for this? I'm ready, let's go.

This is our last paper and then we're gonna get to emails.

In the Annals of Internal Medicine, we have the effect of fluvoxamine and metformin for fatigue in patients with long COVID, an adaptive randomized trial.

This is the Revive Together.